Tags: Coronavirus | Vaccines | coronavirs | vaccine | wuhan

Vaccine Developed in Wuhan Shown 72.5 Percent Effective Against COVID

coronavirus vaccine
(Dreamstime)

Wednesday, 24 February 2021 08:26 AM

Sinopharm Group Co. said its second coronavirus vaccine, this one developed by a subsidiary based in Wuhan, is effective in preventing COVID-19 in 72.5% of people, less than its first shot but above the threshold for approval for general use.

To increase the odds of success, the company’s vaccine subsidiary, China National Biotec Group, launched the development of two inoculations independently in its research institutes in Beijing and Wuhan.

The first shot, developed in Beijing, was effective in preventing COVID-19 in 79.3% of people and has been approved for use in the general population. It has been deployed widely in China and elsewhere around the world.

The company has filed for conditional approval of the second vaccine with China’s National Medical Products Administration on Feb. 21, according to a statement posted on the website of CNBG subsidiary Wuhan Institute of Biological Products Co.

© Copyright 2021 Bloomberg News. All rights reserved.


GlobalTalk
Sinopharm Group Co. said its second coronavirus vaccine, this one developed by a subsidiary based in Wuhan, is effective in preventing COVID-19 in 72.5% of people, less than its first shot but above the threshold for approval for general use...
coronavirs, vaccine, wuhan
143
2021-26-24
Wednesday, 24 February 2021 08:26 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved